Evaluation of the potential utility of NMR spectroscopy to the clinical management of chemotherapy and to the delineation of fundamental processes in tumor biology has been the focus of this research program over the last decade. Our underlying hypothesis is that this method can reliably and noninvasively predict and detect tumor response to chemotherapy. The principal goals of this proposal are 1) to extend our studies to a representative human tumor (MCF-7 breast carcinoma) with histological and pharmacological properties complementary to that of murine radiation-induced fibrosarcoma (RIF-1) examined during the previous funding period, 2) to extend 31P NMR spectroscopic experiments to two nuclei offering unique advantages: 1H, improved spatial resolution and spectral sensitivity; 13C, ability to monitor flux through specific metabolic pathways, 3) to determine the mechanism underlying spectral changes during tumor growth and response to chemotherapy, and 4) to determine the effects of changes in tumor perfusion and proliferation on NMR detectable metabolic characteristics of tumors. Specifically, the utility of 31p, 1H, 13C and 19F NMR spectroscopy as methods for predicting and detecting tumor response to chemotherapy will be compared. A key hypothesis of this proposal is that metabolic flux, because of its sensitivity to perfusion, oxygenation and proliferation, is a more sensitive therapeutic index than steady state measurements of metabolite concentrations. 31p magnetization-transfer and 13C-isotopiC labeling experiments will be used to measure flux through key pathways of tumor energy metabolism. A mathematical model for calculation of flux through the TCA cycle, glycolysis and the hexose monophosphate shunt from the kinetics from '3C-labeling data will be developed. Chemical shift imaging of 31p, 1H and 13C and quantitative morphometry will be employed to examine metabolic heterogeneity. Studies of mechanisms underlying spectral changes will focus on measurements of tumor blood flow and cytokinetics and on in vitro studies of isolated tumor cells and spheroids. The effects of growth stimulation and inhibition on steady state levels of NMR detectable metabolites and flux through key pathways of energy metabolism will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051950-05
Application #
2094475
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1991-04-19
Project End
1996-06-30
Budget Start
1995-04-01
Budget End
1996-06-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Milkevitch, Matthew; Shim, Hyunsuk; Pilatus, Ulrich et al. (2005) Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. Biochim Biophys Acta 1734:1-12
Mancuso, A; Beardsley, N J; Wehrli, S et al. (2004) Real-time detection of 13C NMR labeling kinetics in perfused EMT6 mouse mammary tumor cells and betaHC9 mouse insulinomas. Biotechnol Bioeng 87:835-48
Poptani, Harish; Bansal, Navin; Graham, Robert A et al. (2003) Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed 16:102-11
Poptani, Harish; Bansal, Navin; Jenkins, Walter T et al. (2003) Cyclophosphamide treatment modifies tumor oxygenation and glycolytic rates of RIF-1 tumors: 13C magnetic resonance spectroscopy, Eppendorf electrode, and redox scanning. Cancer Res 63:8813-20
Tailor, Dharmesh R; Poptani, Harish; Glickson, Jerry D et al. (2003) High-resolution assessment of blood flow in murine RIF-1 tumors by monitoring uptake of H(2)(17)O with proton T(1rho)-weighted imaging. Magn Reson Med 49:1-6
Nadal-Desbarats, L; Poptani, H; Oprysko, P et al. (2002) Effects of hyperglycemia on oxygenation, radiosensitivity and bioenergetic status of subcutaneous RIF-1 tumors. Int J Oncol 21:103-10
Duvvuri, U; Poptani, H; Feldman, M et al. (2001) Quantitative T1rho magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy. Cancer Res 61:7747-53
Serrai, H; Nadal-Desbarats, L; Poptani, H et al. (2000) Lactate editing and lipid suppression by continuous wavelet transform analysis: application to simulated and (1)H MRS brain tumor time-domain data. Magn Reson Med 43:649-56
Artemov, D; Bhujwalla, Z M; Pilatus, U et al. (1998) Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy. NMR Biomed 11:395-404
Bhujwalla, Z M; McCoy, C L; Glickson, J D et al. (1998) Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer 78:606-11

Showing the most recent 10 out of 25 publications